Archives
-
Batimastat (BB-94) and Local BDNF Processing
2026-09-24
Explore how Batimastat (BB-94) can help test the role of extracellular MMP activity in spatially organized BDNF processing at developing neuromuscular junctions. This article separates evidence from hypothesis and translates a recent study into practical assay-design decisions.
-
3X FLAG Peptide for Membrane-Protein Research
2026-09-24
The 3X (DYKDDDDK) Peptide can support detection and recovery of tagged proteins, but membrane-contact biology demands careful assay design. Using MIGA2 lipid-transfer research as a case study, this article explains how to separate tag performance from protein function and lipid-dependent assay effects.
-
Homoharringtonine Against SARS-CoV-2: Evidence and Limits
2026-09-23
A 2025 study reports that homoharringtonine inhibited replication of four tested coronaviruses and reduced SARS-CoV-2 in animal and small human cohorts after upper-respiratory delivery. The findings support further investigation of a locally administered antiviral strategy, but the clinical observations are preliminary and do not establish efficacy or safety for routine COVID-19 treatment.
-
Microplastics, Nanoplastics, and Pulmonary Fibrosis
2026-09-23
This study compares polystyrene, polyethylene, and polypropylene microplastics and nanoplastics in mouse and BEAS-2B lung models, showing that polymer identity and particle size shape pulmonary toxicity. Its strongest mechanistic contribution is the identification of FXR-YAP1 dysregulation as a potential pathway linking polystyrene nanoplastic exposure with inflammatory and fibrotic responses.
-
NETs and IL-36R Feedback in Psoriasis
2026-09-22
The reference study identifies a mechanistic feedback loop in which TLR3- and P2X7R-linked signals promote NET formation, while IL-36R activity amplifies cutaneous inflammation. Its combined neutrophil, keratinocyte, and mouse-model experiments support NET–IL-36R signaling as a potential therapeutic axis, while also highlighting the importance of disease timing and model limitations.
-
Localized BDNF Release at Developing Neuromuscular Synapses
2026-09-22
This study identifies podosome-like structures as spatial organizers for muscle-derived BDNF trafficking and calcium-dependent release during the earliest stages of neuromuscular junction development. Its combination of live-cell imaging, proteolytic perturbation, and skeletal muscle-specific knockout experiments links local BDNF processing to aneural and synaptic acetylcholine receptor clustering.
-
Homoharringtonine and SARS-CoV-2: Study Insights
2026-09-21
The reference study combines cell-based, animal, and early patient evidence to examine homoharringtonine as a translation-targeting antiviral against SARS-CoV-2 and other coronaviruses. Its findings support further investigation of localized upper-respiratory delivery, while the small, non-randomized human datasets require cautious interpretation.
-
HyperFluor™ 488 for Viral Organelle Quantification
2026-09-21
HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, multiplex-compatible visualization of goat primary antibodies. This article develops a quantitative assay framework for connecting FXR-driven replication-organelle clustering with rigorous fluorescence controls.
-
HyperFluor 488 for Variant-Vaccine Serology
2026-09-19
Learn how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody can support fluorescence-based human IgG detection while translating variant-vaccine findings into better assay design. This guide emphasizes species matching, controls, endpoint selection, and interpretation limits.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-18
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry. It is intended for research workflows only; users should optimize working dilution and controls experimentally and should not interpret the reagent as validated for diagnostic, therapeutic, or live-cell applications.
-
(-)-Norepinephrine (+)-bitartrate: Assay Guide
2026-09-18
This scenario-based guide explains how (-)-Norepinephrine (+)-bitartrate, SKU C8723, can improve interpretation and reproducibility in adrenergic cell viability, proliferation, and cytotoxicity assays. It addresses salt-form reporting, concentration design, solution handling, data interpretation, and practical supplier selection.
-
(-)-Norepinephrine (+)-bitartrate: Applied Workflows
2026-09-17
Translate adrenergic receptor signaling into reproducible cell, vessel, and cardiomyopathy research workflows with fresh-solution handling and assay-ready concentration planning. A translational section shows how the VNERi framework can connect norepinephrine exposure with vascular responsiveness without confusing an experimental agonist model with clinical treatment.
-
Global Translocon Remodeling During ER Protein Synthesis
2026-09-17
This study uses transcriptome-wide selective ribosome profiling to show that ER translocon composition is remodeled according to the nascent substrate. OST-A preferentially associates with open Sec61 channels during lumenal translocation, whereas GEL, PAT and BOS are recruited together to closed channels during multipass membrane-protein synthesis.
-
WSP-5 Workflow for Live-Cell H2S Imaging
2026-09-16
WSP-5 converts transient hydrogen sulfide signals into a rapid, turn-on fluorescence readout for live cells, donor-release studies, and disease models. This practical guide connects assay design with the diabetic cardiomyopathy literature while emphasizing controls, imaging parameters, and troubleshooting.
-
FGFR2::SHTN1 Fusion: Shootin1-Driven Activation
2026-09-16
This study provides the first molecular characterization of the FGFR2::SHTN1 fusion and proposes that Shootin1 coiled-coil domains drive ligand-independent FGFR2 dimerization. Its combined genomic, biochemical, and structural analyses clarify how a protein best known for neuronal cytoskeletal regulation may become an oncogenic fusion partner, particularly in cholangiocarcinoma.